Ocean Biomedical Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Ocean Biomedical.

Analyst Consensus: n/a

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

There are currently no analyst ratings available for OCEA.

Recommendation Trends

Rating	Apr '23	May '23
Strong Buy	2	0
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	2	0

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Howard Halpern Taglich Brothers	Taglich Brothers	Buy Initiates $20	Buy	Initiates	$20	+1,718.18%	May 31, 2023
Tony Butler EF Hutton	EF Hutton	Strong Buy Initiates $17	Strong Buy	Initiates	$17	+1,445.45%	May 25, 2023
Michael King EF Hutton	EF Hutton	Strong Buy Maintains $10 → $17	Strong Buy	Maintains	$10 → $17	+1,445.45%	Apr 27, 2023
Michael King EF Hutton	EF Hutton	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+809.09%	Apr 13, 2023
Sid Rajeev Fundamental Research Corp.	Fundamental Research Corp.	Strong Buy Initiates $16	Strong Buy	Initiates	$16	+1,390.91%	Mar 16, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-3.14

from -0.99

EPS Next Year

-0.91

from -3.14

Year	2021	2022	2023	2024
Revenue	-	-	-	-
Revenue Growth	-	-	-	-
EPS	-3.57	-0.99	-3.14	-0.91
EPS Growth	-	-	-	-
Forward PE	-	-	-	-
No. Analysts	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2023	2024
High	n/a	n/a
Avg	n/a	n/a
Low	n/a	n/a

Revenue Growth

Revenue Growth	2023	2024
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2023	2024
High	-3.23	-0.93
Avg	-3.14	-0.91
Low	-3.02	-0.87

EPS Growth

EPS Growth	2023	2024
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.